HK Stock Market Move | "Medical Imaging Big Data Model Leader" DIAGENS-B (02526) Soars Over 21%, Market Value Surpasses HK$20 Billion

DIAGENS-B(02526) surged more than 21%, reaching a high of 242 Hong Kong dollars during trading, setting a new record high. As of the time of writing, the stock was up 21.11%, at 239.8 Hong Kong dollars, with a trading volume of 659.241 million Hong Kong dollars, and a market value surpassing 20 billion Hong Kong dollars. Public information shows that since its establishment in 2016, Deepwise has focused on the underlying technological innovation in the field of AI medical imaging. The company's independently developed iMedImage medical image base model supports 19 image modes and can empower over 90% of clinical imaging scenarios. iMedImage is based on massive pre-training data and can quickly train disease-specific imaging models, achieving an important breakthrough in the industry of "low sample, low computing power, fast training". In addition, the company's core product AI AutoVision has been recognized by the National Medical Products Administration as a Category III Innovative Medical Management device, and is expected to become the first intelligent chromosomal karyotyping assistant diagnostic software to be approved and launched nationwide. In terms of finances, in the first 9 months of 2025, the company achieved a year-on-year revenue increase of 469.8% to 1.12 billion yuan, with a high gross profit margin of 75.9%, and a gross profit margin of 96.5% for technology licensing business. As of September 2025, the company's products have been deployed in over 400 medical institutions nationwide, with a utilization rate of 40% in the top ten hospitals in China, demonstrating initial commercialization capabilities.